Gary B. Gordon insider trades: TriSalus Life Sciences (TLSI) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Gary reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | TLSI | ↑ Buy | 9,756 | $4.10 | $40K | Direct | Feb 23, 2026 (0d) |
| Feb 24, 2021 | AYLA | ↓ Sell | 3,000 | $17.46 | $52K | Direct | Feb 26, 2021 (2d) |
| Jan 20, 2021 | AYLA | ↓ Sell | 3,000 | $15.03 | $45K | Direct | Jan 22, 2021 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TLSI insiders
Open-market trades in the last 12 months
About Gary B. Gordon's insider trades
Gary B. Gordon is a director at TriSalus Life Sciences (TLSI). Since Jan 20, 2021, Gary has reported 1 open-market purchase worth $40K and 2 sales worth $97K on SEC Form 4. In the last 12 months: 1 buy ($40K).
Their filings also include grants and awards (6 filings), option exercises (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TLSI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.